Intelligence · Patents
Patents expiring in 2027
Annual patent cliff calendar for 2027 — US pharmaceutical patents by expiration date.
- Patents
- 599
Quick answer
599 indexed pharmaceutical patents have expiration dates in 2027. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 7196184
Double-stranded RNA (DSRNA) and method of use for inhibiting expression of the AML-1/MTG8 fusion gene
granted -
US 7196098
Quinuclidine derivatives and medicinal compositions containing the same
granted -
US 7196074
Methods of making, using and pharmaceutical formulations comprising 7α, 11β-dimethyl-17β-hydroxyestra-4, 14-dien-3-one and 17 esters thereof
granted -
US 7195911
Mammalian cells that have increased proliferative capacity
granted -
US 7196119
Development of new selective estrogen receptor modulators
granted -
US 7195778
Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
granted -
US 7196205
Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
granted -
US 7199114
Triterpene quaternary salts as biologically active surfactants
granted -
US 7199102
Orally administered peptides synergize statin activity
granted -
US 7199127
Purine nucleosides
granted -
US 7199103
Synthetic compounds and compositions with enhanced cell binding
granted -
US 7198783
Sensitization of neoplastic cells to radiation therapy with reovirus
granted -
US 7199157
Use of treprostinil to improve kidney functions
granted -
US 7198947
Production of functional proteins: balance of shear stress and gravity
granted -
US 7199223
Polymer-factor VIII moiety conjugates
granted -
US 7198788
Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26.
granted -
US 7198949
Compositions and methods for altering the biodistribution of biological agents
granted -
US 7199124
JNK inhibitor
granted -
DE 102005046769
Lichtstabile, brivudinhaltige pharmazeutische Formulierung zur Behandlung von Augenherpes (Herpes Ophthalmicus)
granted -
US 7201911
Cloned genomes of infectious hepatitis C viruses and uses thereof
granted -
US 7202045
Detection and treatment of cancers of the lung
granted -
US 7201902
Production of recombinant protein pap 31 for the diagnosis and prevention of Bartonella bacilliformis infection
granted -
US 7202262
Benzoic acid or benzoate substituted 1,2,4-oxadiazole compounds and their use for the treatment of disease
granted -
US 7202040
Method for screening compounds which change the binding properties of a protein with a ligand
granted -
US 7202087
Anticoagulant composition
granted -
US 7201920
Methods and compositions for deterring abuse of opioid containing dosage forms
granted -
US 7201907
Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines
granted -
US 7205305
Inhibitors of p38
granted -
US 7205334
Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof
granted -
US 7205411
Aminopyridine derivatives as mGluR5 antagonists
granted -
US 7204996
Method of cancer treatment
granted -
US 7204993
Streptococcus agalactiae vaccine
granted -
US 7205380
Sterically hindered poly (ethylene glycol) alkanoic acids and derivatives thereof
granted -
US 7204982
Compositions and methods for treatment and detection of multiple cancers
granted -
US 7205327
Imidazole and benzimidazole caspase inhibitors and uses thereof
granted -
US 7205006
Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
granted -
US 7205005
Medicament containing epidemium extract for treatment of prostatic hyperplasia and prostatitis
granted -
US 7205011
Anti-inflammatory activity of a specific turmeric extract
granted -
US 2007086944
CONJUGATES OF ANTIOXIDANTS WITH METAL CHELATING LIGANDS FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
granted -
US 7208145
Polymeric reagents comprising a ketone or a related functional group
granted -
US 7208289
Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein
granted -
US 7208161
Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
granted -
US 7208602
Gamma secretase inhibitors
granted -
US 7208600
Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases
granted -
US 7208612
Crystals of LuxP and complexes thereof
granted -
US 7208579
IL4 receptor antagonists for horse, dog and cat
granted -
US 7208478
Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
granted -
US 7208515
Diphenylmethyl compounds useful as muscarinic receptor antagonists
granted
Frequently asked questions
How many pharma patents expire in 2027?
599 published patents in our USPTO index have expiration dates falling in calendar year 2027.